3Li K,Wang L,Cheng J,et al.Interaction between hepatitis C virus core protein and translin protein-a possible molecular mechanism for hepatocellular carcinoma and lymphoma caused by hepatitis C virus.World J Gastroenterol,2003,9(2):300.
5[9]Pawlotsky JM, Germanidis G. The non-structural 5A protein of hepatitis C virus. J Viral Hepat 1999;6:343-356
6[10]Lan KH, Sheu ML, Hwang SJ, Yen SH, Chen SY, Wu JC, Wang YJ, Kato N, Omata M, Chang FY, Lee SD. HCV NS5A interacts with p53 and inhibits p53-mediated apoptosis. Oncogene 2002;21:4801-4811
7[11]Urbani S, Uggeri J, Matsuura Y, Miyamura T, Penna A, Boni C, Ferrari C. Identification of immunodominant hepatitis C virus (HCV)-specific cytotoxic T-cell epitopes by stimulation with endogenously synthesized HCV antigens. Hepatology 2001;33:1533-1543
8[12]Hue S, Cacoub P, Renou C, Halfon P, Thibault V, Charlotte F,Picon M, Riffiet H, Piette JC, Poi S, Caillat-Zucman S. Human leukocyte antigen class Ⅱ alleles may contribute to the severity of hepatitis C virus-related liver disease. J Infect Dis 2002;186:106-109
9[13]Penna A, Missale G, Lamonaca V, Pilli M, Mori C, Zanelli P,Cavalli A, Elia G, Ferrari C. Intrahepatic and circulating HLA class Ⅱ-restricted, hepatitis C virus-specific T cells: functional characterization in patients with chronic hepatitis C.Hepatology 2002;35:1225-1236
10[14]Nelson DR. The immunopathogenesis of hepatitis C virus infection. Clin Liver Dis 2001;5:931-953
